, Tracking Stock Market Picks
Enter Symbol:
Medarex, Inc. (MEDX) [hlAlert]

up 119.45 %

Medarex, Inc. (MEDX) rated Buy with price target $11 by Needham

Posted on: Tuesday,  May 13, 2008  8:25 AM ET by Needham

Needham rated Buy Medarex, Inc. (NASDAQ: MEDX) on 05/13/2008, when the stock price was $7.30. Since
then, Medarex, Inc. has gained 119.45% as of 09/01/2009's recent price of $16.02.
If you would have followed this Needham's recommendation on MEDX, you would have gained 119.45% of your investment in 476 days.

Medarex Inc. is a biopharmaceutical company developing monoclonal antibody-based therapeutics to fight cancer and other life-threatening and debilitating diseases. The company has developed a broad platform of patented technologies for antibody discovery and development, including the HuMAb-Mouse system for the creation of high-affinity human antibodies.Medarex creates and develops human antibodies for itself and others, offering a full range of antibody development capabilities, including pre-clinical and clinical manufacturing services. (PRESS RELEASE)

Needham & Company, LLC focuses on emerging growth companies in technology, biotechnology and life sciences. The firm's research goal is to service the needs of growth-oriented institutional clients. Needham & Company has established itself as a premier specialty investment bank providing timely and valuable analysis on companies that are under-covered by the majority of Wall Street firms.
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
5/13/2008 8:25 AM Buy
7.30 11.00
as of 12/24/2008
1 Week up  7.78 %
1 Month up  29.73 %
3 Months up  17.31 %
1 YTD up  14.15 %

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy